IO BIOTECH INC (IOBT) Stock Balance Sheet
NASDAQ:IOBT - Nasdaq - US4497781090 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 80.19M | 143.19M | 142.60M | 211.50M | 3.40M | |||
| Receivables | 964.00K | 1.13M | 1.50M | 2.10M | 1.50M | |||
| Other Current Assets | 5.09M | 2.94M | 4.10M | 8.10M | 700.00K | |||
| Total Current Assets | 86.24M | 147.25M | 148.20M | 221.70M | 5.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.51M | 3.11M | 3.20M | N/A | N/A | |||
| Other Non-Current Assets | 1.19M | 357.00K | 400.00K | 600.00K | 0.00 | |||
| Total Non-Current Assets | 3.70M | 3.46M | 3.60M | 600.00K | 100.00K | |||
| TOTAL ASSETS | 89.94M | 150.72M | 151.80M | 222.30M | 5.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.43M | 11.03M | 4.30M | 5.90M | 2.50M | |||
| Accounts Payable | 5.26M | 3.88M | 4.00M | 3.90M | 500.00K | |||
| Other Current Liabilities | 1.37M | 806.00K | 2.40M | 500.00K | 0.00 | |||
| Total Current Liabilities | 16.05M | 15.72M | 10.70M | 10.30M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.32M | 1.84M | 2.30M | 100.00K | 0.00 | |||
| Total Non-Current Liabilities | 1.32M | 1.84M | 2.30M | 100.00K | 0.00 | |||
| TOTAL LIABILITIES | 17.38M | 17.56M | 13.00M | 10.40M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -327.98M | -263.82M | -177.70M | -106.30M | -38.40M | |||
| Additional Paid In Capital | 411.48M | 406.59M | 326.70M | 319.70M | 1.10M | |||
| Common Shares | 66.00K | 66.00K | 0.00 | 0.00 | 37.90M | |||
| Other Shareholders' Equity | -11.00M | -9.67M | -10.10M | -1.50M | 2.00M | |||
| Shares Outstanding | 65.88M | 65.88M | 28.80M | 28.80M | 27.70M | |||
| Tangible Book Value per Share | 1.10 | 2.02 | 4.82 | 7.36 | -1.27 | |||
| Total Shareholders' Equity | 72.56M | 133.16M | 138.90M | 211.90M | 2.60M | |||
| TOTAL LIABILITIES AND EQUITY | 89.94M | 150.72M | 151.80M | 222.30M | 5.70M | |||
| Statistics | ||||||||
| Current Ratio | 5.37 | 9.37 | 13.85 | 21.52 | 1.81 | |||
| Return On Assets (ROA) | -100.44% | -57.12% | -47.08% | -33.73% | -255.96% | |||
| Return On Equity (ROE) | -124.50% | -64.65% | -51.45% | -35.39% | -561.15% | |||
All data in USD , ROIC based on taxRate of 0.21